Curcuma Forte 60t

$119.95 AUD

Description

Description:

Curcuma Active contains all 3 curcuminoids found in Turmeric (curcumin 70-75%, demethoxy curcumin 15-20% and bisdemethoxycurcumin 5-10%) bound to a Sunflower oil derived Curcumin-Phospholipid Complex.

Indications

  • Supports joint mobility and flexibility and reduces mild joint swelling and stiffness associated with mild arthritis.
  • Anti-inflammatory.
  • Reduces mild rheumatic aches and pains.
  • Decreases symptoms of mild arthritis, including mild joint pain.
  • Maintains joint health.
  • Antioxidant - reduces free radicals formed in the body.

Dose

Adults: Take 1 to 2 tablets daily.

Ingredients

Each tablet contains:
Curcuma longa phospholipid complex 500 mg
Derived from rhizome fresh 16.5 g
Standard to contain curcuminoids 100 mg

Allergen Information

  • No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours.
  • Vegan friendly.

Excipients

Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, croscarmellose sodium, crospovidone, hypromellose, lecithin (sunflower), magnesium stearate, microcrystalline cellulose, sodium starch glycollate.

Warning

  • Despite Turmeric and curcumin having low toxicity, caution is advised (due to the increased bioavailability) for the use of curcumin phospholipid complex during pregnancy, women wishing to conceive, and patients taking prescribed medications, such as those with a narrow therapeutic window and/or antiplatelet or anticoagulant drugs.
  • Monitoring is advised for patients taking anti-inflammatory drugs, as the reduced dosage of the drug may be possible.
  • Contraindicated in obstruction of the biliary tract, caution is advised in gallstones.
  • Until more information is available regarding the expression of Nrf2 in cancer, do not take at least 48 hours on either side of each chemotherapy or radiotherapy treatment.
  • Not to be used in children under five years of age.
  • Discontinue 7 days prior to general anaesthesia.
  • Caution in patients taking tacrolimus. Caution with long-term use in patients taking etoricoxib.
  • If patient symptoms persist, seek additional professional advice.